查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999332

膠囊內視鏡市場：2026-2032年全球市場預測（依產品類型、內視鏡模式、年齡層、應用程式、通路和最終用戶分類）

Capsule Endoscopy Market by Product Type, Endoscopy Mode, Age Group, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，膠囊內視鏡市場價值將達到 5.4109 億美元，到 2026 年將成長至 5.8389 億美元，到 2032 年將達到 9.4449 億美元，複合年成長率為 8.28%。

主要市場統計數據
基準年 2025 5.4109億美元
預計年份：2026年 5.8389億美元
預測年份 2032 9.4449億美元
複合年成長率 (%) 8.28%

探索膠囊內視鏡技術在重新定義非侵入性胃腸道診斷以改善患者預後的變革性作用。

膠囊內視鏡徹底革新了胃腸道診斷，它以一個可吞嚥的膠囊取代了傳統的侵入性內視鏡檢查。這種膠囊體積小巧，內建高解析度成像感測器，使臨床醫生能夠以前所未有的方式觀察以往難以成像的小腸區域。因此，與傳統內視鏡檢查相比，患者的不適感和風險都大大降低，從而提高了需要定期進行胃腸道檢查的患者的就診率。

識別塑造膠囊內視鏡未來發展的關鍵技術和監管變革，並推動全球胃腸道成像領域的創新。

技術突破正推動膠囊內視鏡領域發生前所未有的變革，模糊了診斷與數據驅動決策之間的界線。近期推出的超高解析度成像晶片帶來了前所未有的清晰度，能夠偵測到以往無法察覺的微小黏膜病變。同時，電源管理技術的進步延長了膠囊電池的使用壽命，使其能夠更長時間地通過消化道，從而確保從食道到結腸的全面可視化。

評估 2025 年美國關稅調整對全球膠囊內視鏡供應鏈和市場動態的累積影響。

2025年，美國關稅調整的實施將為膠囊內視鏡供應鏈帶來新的挑戰，迫使相關人員重新評估籌資策略和成本結構。傳統上依賴從主要製造地進口零件的設備製造商，如今正面臨專用成像感測器、微型電池單元和無線傳輸模組等零件關稅上漲的困境。因此，生產成本不斷攀升，迫使製造商尋求替代供應商並建立策略夥伴關係，以緩解關稅帶來的價格壓力。

關鍵細分見解，包括產品變體、內視鏡模式、年齡層、臨床應用、分銷管道和最終用戶類別。

詳細的細分分析揭示了不同產品配置和臨床背景如何影響市場接受度的明顯趨勢。例如，結腸膠囊內視鏡系統因其專為結腸評估而設計而備受關注，而食道和小腸平台則針對特定的診斷場景。每個產品層級都展現出獨特的性能特徵，從針對食道通過而最佳化的膠囊尺寸到專為小腸成像設計的高級光學塗層，不一而足。

分析美洲、歐洲、中東和非洲以及亞太市場引入膠囊內視鏡的區域趨勢和成長要素。

在整個美洲，尤其是在北美市場，對胃腸道診斷基礎設施的投資正在加速成長，膠囊內視鏡作為一種首選的非侵入性檢查方式正日益普及。有利的保險報銷政策和較高的結直腸癌篩檢計畫覆蓋率正鼓勵臨床醫生將膠囊內視鏡系統納入其常規通訊協定。在拉丁美洲，不斷成長的醫療保健預算和公共衛生舉措也促進了膠囊內視鏡的普及，儘管各國在成本考量和監管時間表方面存在差異。

介紹推動膠囊內視鏡市場創新和策略合作的關鍵產業領導者。

產業領導企業正透過融合技術實力和策略夥伴關係關係來提升膠囊內視鏡的臨床效用，從而實現差異化競爭。大型跨國公司正大力投資於改進高解析度成像技術和延長電池壽命，並與研究機構合作，在同行評審期刊上發表研究成果以檢驗其發現。這些合作關係能夠快速改善即時資料傳輸和位置感測器整合等設計功能，從而提高檢查效率和診斷準確性。

為產業領導者提供切實可行的建議，以加強其技術採用、營運效率、監管合規性和市場定位策略。

產業領導者應優先考慮將人工智慧功能整合到膠囊內視鏡平台中，以提高病灶檢測準確率並縮短影像解讀時間。透過整合能夠自動標記異常的機器學習演算法，製造商可以提供全面的診斷工作流程，從而減輕臨床醫生的負擔並加快患者照護過程。同時，投資於模組化設計原則和靈活的生產結構將有助於企業適應不斷變化的法規環境並最大限度地降低供應鏈風險。

概述了為確保對行業趨勢、數據來源檢驗和膠囊內視鏡市場進行全面分析而採用的調查方法。

本研究結合了對同行評審期刊、監管文件和臨床試驗資料庫的系統性回顧，以及對頂尖胃腸病學家、醫療設備工程師和採購專家的深入訪談。嚴謹的資訊來源檢驗確保了定性研究結果在多個資料點上得到交叉檢驗，從而提高了新興趨勢分析的可靠性。二級資訊來源包括醫學協會發布的白皮書和監管機構發布的指南，這些資料為評估核准時間表和上市後監測要求提供了框架。

膠囊內視鏡在現代胃腸道診斷中的演變、整合和未來前景的總結性觀點。

隨著膠囊內視鏡技術的不斷發展，其對胃腸道診斷的變革性影響日益顯著。從超高解析度成像技術的進步到與遠距遠端醫療平台無縫整合的數據整合，這些口服型設備正在重塑臨床醫生的工作流程和患者的就醫體驗。監管政策的調整和合作研究舉措正在加速創新週期，推動從一次性膠囊向利用人工智慧和先進感測器技術的智慧系統轉型。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 膠囊內視鏡市場：依產品類型分類

  • 結腸膠囊內視鏡檢查
  • 食道膠囊內視鏡
  • 小腸膠囊內視鏡檢查

第9章 依內視鏡模式分類的膠囊內視鏡市場

  • 可重複使用的膠囊
  • 免洗膠囊

第10章：膠囊內視鏡市場：依年齡層別分類

  • 成人版
  • 老年人
  • 兒童

第11章 膠囊內視鏡市場：依應用領域分類

  • 乳糜瀉
  • 大腸直腸癌篩檢
  • 克隆氏症
  • 胃食道逆流症
  • 不明原因消化道出血（OGIB）
  • 小腸腫瘤
  • 潰瘍檢測

第12章 膠囊內視鏡市場：依通路分類

  • 離線
  • 線上

第13章 膠囊內視鏡市場：依最終用戶分類

  • 門診手術中心（ASC）
  • 診斷中心
  • 醫院
  • 研究機構

第14章 膠囊內視鏡市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 膠囊內視鏡市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 膠囊內視鏡市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國膠囊內視鏡市場

第18章：中國膠囊內視鏡市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advin Health Care
  • Anx Robotica Corp.
  • Beijing Richen-Force Science & Technology Co.,Ltd
  • Biocam Sp. z oo
  • CapsoVision, Inc.
  • Covestro AG
  • Duomed Group
  • Fujifilm Holding Corporation
  • Intromedic co., Ltd
  • JINSHAN Science & Technology（Group）Co., Ltd.
  • Medtronic PLC
  • MU Ltd.
  • Olympus Corporation
  • RF Systems Lab
  • Shangxian Minimal Invasive Inc
  • STERIS
  • SynMed Ltd.
Product Code: MRR-3A2E844FDE44

The Capsule Endoscopy Market was valued at USD 541.09 million in 2025 and is projected to grow to USD 583.89 million in 2026, with a CAGR of 8.28%, reaching USD 944.49 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 541.09 million
Estimated Year [2026] USD 583.89 million
Forecast Year [2032] USD 944.49 million
CAGR (%) 8.28%

Exploring the Transformative Role of Capsule Endoscopy Technologies in Redefining Noninvasive Gastrointestinal Diagnostics for Enhanced Patient Outcomes

Capsule endoscopy represents a landmark innovation in gastrointestinal diagnostics by replacing traditional invasive endoscopic procedures with a single swallowable device. The discreet nature of the capsule, equipped with high-definition imaging sensors, offers clinicians unrivaled access to deep sections of the small intestine that were previously challenging to visualize. As a result, patients experience reduced discomfort and risk compared to conventional endoscopy, fostering higher compliance rates among individuals requiring regular gastrointestinal assessment.

Initial trials and subsequent clinical adoption have underscored the value of this technology in detecting a spectrum of conditions, ranging from obscure gastrointestinal bleeding to suspected small intestine tumors. Enhanced illumination systems and expanded battery life have significantly increased the diagnostic yield, allowing longer transit durations and continuous image capture throughout the digestive tract. Coupled with wireless data acquisition platforms, these improvements have streamlined workflow for medical teams while offering real-time insights into patient health.

Looking ahead, ongoing research is focused on integrating advanced analytics and artificial intelligence into the capsule endoscopy framework. By leveraging machine learning algorithms to flag potential anomalies and cross-reference patient histories, the next generation of capsule endoscopy promises both heightened accuracy and accelerated reporting. This evolution underscores the critical role of capsule endoscopy in shaping future standards for noninvasive gastrointestinal care

Identifying Major Technological and Regulatory Shifts Shaping the Capsule Endoscopy Landscape and Driving Innovation in Gastrointestinal Imaging Worldwide

Technological breakthroughs have catalyzed an unparalleled transformation in the capsule endoscopy landscape, blurring the lines between diagnostics and data-driven decision making. Recent introductions of ultra-high-resolution imaging chips have delivered unprecedented clarity, enabling the detection of minute mucosal lesions that would have previously gone unnoticed. Meanwhile, advancements in power management have extended capsule battery life, permitting extended transit through the gastrointestinal tract and ensuring comprehensive visualization from the esophagus to the colon.

Simultaneously, regulatory frameworks have evolved to accommodate the growing complexity of ingestible diagnostic devices. Medical agencies across key markets have introduced expedited pathways for novel capsule designs and enhanced post-market surveillance protocols. These regulatory shifts have encouraged manufacturers to innovate aggressively while maintaining rigorous safety and efficacy standards. Consequently, the market has witnessed a surge in clinical collaborations aimed at validating new imaging modalities, including optical coherence tomography and hyperspectral analysis, within a capsule format.

In parallel, the convergence of telemedicine platforms and remote patient monitoring tools has redefined the patient experience. Physicians can now review capsule imagery in real time, and patients benefit from streamlined pre-procedure instructions and post-procedure consultations without in-person visits. These transformative shifts underscore an industry moving rapidly toward integrated care models, where capsule endoscopy functions not only as a diagnostic instrument but also as a key element in a broader digital health ecosystem

Evaluating the Cumulative Effects of the 2025 United States Tariff Adjustments on Global Capsule Endoscopy Supply Chains and Market Dynamics

In 2025, the imposition of updated United States tariffs has introduced a new set of challenges for the capsule endoscopy supply chain, prompting stakeholders to reevaluate sourcing strategies and cost structures. Historically reliant on components imported from major manufacturing hubs, device producers are now navigating elevated duties on specialized imaging sensors, microbattery units, and wireless transmission modules. As a result, production costs have risen, compelling manufacturers to explore alternative suppliers and form strategic partnerships to mitigate tariff-induced price pressures.

Moreover, these tariff adjustments have created ripple effects across distribution networks, with importers and healthcare providers facing higher acquisition expenses. Many hospitals and diagnostic centers have responded by renegotiating procurement agreements and seeking volume-based pricing arrangements to preserve budgetary margins. In tandem, suppliers are investing in domestic assembly capabilities and localized manufacturing initiatives to offset the financial impact of cross-border trade barriers. These activities have fostered greater supply chain resilience and have accelerated the implementation of nearshore production models.

Looking forward, industry participants are also advocating for policy dialogues to balance trade objectives with healthcare affordability. While tariffs aim to bolster domestic industrial growth, the ultimate concern remains the accessibility and pricing of life-saving diagnostic technologies. Stakeholders are therefore engaging with policymakers and trade associations to ensure that tariff frameworks evolve in a manner that sustains innovation while protecting patient access to advanced gastrointestinal diagnostics

Unveiling Critical Segmentation Insights for Product Variants Endoscopy Modes Age Groups Clinical Applications Distribution Channels and End User Categories

An in-depth segmentation analysis reveals distinct patterns in how different product configurations and clinical contexts shape market uptake. For instance, colon capsule endoscopy systems have gained prominence due to their targeted design for colorectal evaluation, while esophageal and small bowel platforms address specialized diagnostic scenarios. Each product tier demonstrates unique performance attributes, from capsule dimensions optimized for esophageal transit to advanced optical coatings engineered for small-bowel imaging.

Equally important is the differentiation by endoscopy mode, where reusable capsules are preferred for high-volume diagnostic centers seeking cost efficiencies, and single-use models appeal to institutions prioritizing sterility and patient safety. Age demographics further refine this picture, with adult patients representing the core user base, geriatric cohorts demanding minimally invasive options due to comorbidities, and pediatric applications driving innovation in capsule miniaturization.

Clinical applications present another layer of granularity, as the technology is employed for celiac disease monitoring, colon cancer screening, Crohn's disease assessment, gastroesophageal reflux evaluation, obscure gastrointestinal bleeding investigation, small intestine tumor detection, and precise ulcer identification. Distribution channels vary from established offline networks encompassing medical device distributors to emerging online portals that facilitate direct procurement. Finally, end users span ambulatory surgical centers seeking streamlined workflows, diagnostic centers focused on outpatient throughput, hospitals integrating capsule endoscopy into broader GI service lines, and research institutes exploring next-generation functionalities

Highlighting Regional Dynamics and Growth Drivers for Capsule Endoscopy Adoption across the Americas Europe Middle East Africa and Asia Pacific Markets

Across the Americas, particularly in North American markets, investment in gastrointestinal diagnostic infrastructure has accelerated the adoption of capsule endoscopy as a preferred noninvasive option. Favorable reimbursement policies and a high prevalence of colorectal cancer screening programs have driven clinicians to incorporate capsule systems into routine protocols. In Latin America, growing healthcare budgets and public health initiatives are fostering incremental uptake, although cost considerations and regulatory timelines vary by country.

Within Europe, the Middle East and Africa region, heterogeneous reimbursement landscapes pose both opportunities and challenges. Western European nations benefit from well-established reimbursement codes and robust clinical guidelines, which have enabled consistent integration of capsule endoscopy into gastroenterology practices. Conversely, parts of the Middle East are characterized by rapid modernization of healthcare facilities, leading to significant adoption surges in urban centers, while certain African markets remain constrained by limited specialist availability and infrastructure gaps.

The Asia-Pacific market exhibits dynamic growth driven by expanding healthcare access and rising awareness of digestive health issues. Countries such as Japan and South Korea, with advanced manufacturing capabilities and supportive regulatory frameworks, continue to lead in capsule endoscopy innovation. Meanwhile, emerging economies in Southeast Asia and India are witnessing increased demand for cost-effective, noninvasive diagnostic modalities, fueled by public screening campaigns and telemedicine integration. These regional dynamics underscore the importance of tailored market entry and engagement strategies

Showcasing Key Industry Leaders Driving Innovation and Strategic Collaborations in the Evolving Capsule Endoscopy Market Landscape

Industry leaders have distinguished themselves through a blend of technological prowess and strategic partnerships aimed at advancing the clinical utility of capsule endoscopy. Major multinational corporations have invested heavily in high-definition imaging enhancements and extended battery solutions, collaborating with research institutions to validate their contributions in peer-reviewed studies. These alliances have enabled rapid iteration of design features, such as real-time data transmission and integrated localization sensors, which enhance procedural efficiency and diagnostic accuracy.

Mid-tier manufacturers have likewise carved out specialized niches by focusing on cost-effective capsule platforms optimized for specific clinical segments, including pediatric applications and outpatient screening programs. These companies often leverage modular production frameworks to respond swiftly to evolving regulatory requirements and customer feedback. Collaborative agreements with hospitals and diagnostic clinics have facilitated field trials, enabling iterative refinement of software algorithms that support lesion detection and report generation.

In addition to hardware innovation, several key players have formed ecosystem partnerships with telehealth providers and cloud service operators to deliver end-to-end diagnostic solutions. This trend underscores a shift toward value-based care models, where capsule endoscopy emerges as a central component of integrated gastrointestinal health management. Collectively, these strategic activities reflect a competitive landscape where agility, clinical validation, and cross-sector collaborations define market leadership

Actionable Recommendations for Industry Leaders to Enhance Technological Adoption Operational Efficiency Regulatory Compliance and Market Positioning Strategies

Industry leaders should prioritize the integration of artificial intelligence capabilities into their capsule endoscopy platforms to enhance lesion detection accuracy and reduce interpretation times. By embedding machine learning algorithms capable of automated anomaly flagging, manufacturers can offer comprehensive diagnostic workflows that alleviate clinician burden and expedite patient care pathways. In parallel, investment in modular design principles and flexible manufacturing arrangements will help companies navigate evolving regulatory environments and minimize supply chain vulnerabilities.

Strategic partnerships with both domestic and nearshore component suppliers can mitigate the financial impact of cross-border tariffs while supporting more resilient production networks. Engaging proactively with regulatory agencies to secure expedited review pathways will further accelerate time-to-market for next-generation systems. In terms of market expansion, targeting emerging regions through customized reimbursement models and training programs can unlock new user bases, particularly in underserved areas where gastrointestinal conditions impose significant healthcare burdens.

Finally, healthcare providers and device developers alike should cultivate collaborative networks with telemedicine and digital health service providers. Offering integrated diagnostic packages that combine capsule endoscopy with remote patient monitoring and virtual follow-up consultations will align with broader value-based care initiatives. These actionable strategies will empower stakeholders to optimize diagnostic performance, reinforce market positioning, and deliver superior patient outcomes

Outlining the Research Methodology Employed to Capture Industry Trends Validate Data Sources and Ensure Thorough Analysis of Capsule Endoscopy Market Insights

This research effort combined a systematic review of peer-reviewed journals, regulatory filings, and clinical trial databases with in-depth interviews conducted with leading gastroenterologists, device engineers, and procurement specialists. Rigorous source triangulation ensured that qualitative insights were cross-validated against multiple data points, enhancing the reliability of emerging trend analysis. Secondary sources included white papers from professional medical societies and guidelines published by regulatory agencies, which provided a framework for assessing approval timelines and post-market surveillance requirements.

Primary research involved structured discussions with senior clinicians who have pioneered capsule endoscopy adoption in diverse clinical settings, alongside conversations with technical experts responsible for device design and integration. Feedback from procurement teams across ambulatory centers and hospitals shed light on distribution channel dynamics and purchasing decision criteria. All insights were synthesized through a multi-stage analytical process, which encompassed thematic coding to identify core drivers, barriers, and innovation hotspots. These findings were then subjected to peer review by an experienced advisory panel to ensure comprehensive coverage and unbiased interpretation. Through this methodology, the study delivers a robust and nuanced understanding of the capsule endoscopy ecosystem

Drawing Conclusive Perspectives on the Evolution Integration and Future Outlook of Capsule Endoscopy in Modern Gastrointestinal Diagnostics

As capsule endoscopy technologies continue to evolve, their transformative impact on gastrointestinal diagnostics is becoming increasingly evident. From ultra-high-resolution imaging enhancements to seamless data integration within telehealth platforms, these ingestible devices are redefining clinician workflows and patient experiences alike. Regulatory adaptations and collaborative research initiatives have accelerated innovation cycles, driving the transition from single-use capsules toward intelligent systems powered by artificial intelligence and advanced sensor modalities.

The cumulative effect of U.S. tariff adjustments in 2025 highlights the importance of resilient supply chain strategies and nearshore manufacturing capabilities. Meanwhile, segmentation analysis underscores distinct preferences among clinical applications, age groups, and endoscopy modes, offering manufacturers opportunities to tailor solutions to specific market niches. Regional dynamics in the Americas, EMEA, and Asia-Pacific further illustrate the necessity of localized approaches that consider reimbursement landscapes, infrastructure maturity, and patient awareness levels.

Looking ahead, stakeholders who embrace modular design, foster strategic ecosystem partnerships, and prioritize regulatory alignment will be best positioned to capture the next wave of growth. The evolution of capsule endoscopy is not simply a technological journey, but a paradigm shift toward patient-centric, data-driven healthcare. As this field matures, it will play an integral role in holistic gastrointestinal care pathways, empowering clinicians with tools that deliver precision, efficiency, and enhanced patient outcomes

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Capsule Endoscopy Market, by Product Type

  • 8.1. Colon Capsule Endoscopy
  • 8.2. Esophageal Capsule Endoscopy
  • 8.3. Small Bowel Capsule Endoscopy

9. Capsule Endoscopy Market, by Endoscopy Mode

  • 9.1. Reusable Capsules
  • 9.2. Single Use Capsules

10. Capsule Endoscopy Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Capsule Endoscopy Market, by Application

  • 11.1. Celiac Disease
  • 11.2. Colon Cancer Screening
  • 11.3. Crohn's Disease
  • 11.4. Gastroesophageal Reflux Disease
  • 11.5. Obscure Gastrointestinal Bleeding (OGIB)
  • 11.6. Small Intestine Tumors
  • 11.7. Ulcer Detection

12. Capsule Endoscopy Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Capsule Endoscopy Market, by End User

  • 13.1. Ambulatory Surgical Centers (ASCs)
  • 13.2. Diagnostic Centers
  • 13.3. Hospitals
  • 13.4. Research Institutes

14. Capsule Endoscopy Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Capsule Endoscopy Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Capsule Endoscopy Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Capsule Endoscopy Market

18. China Capsule Endoscopy Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Advin Health Care
  • 19.6. Anx Robotica Corp.
  • 19.7. Beijing Richen-Force Science & Technology Co.,Ltd
  • 19.8. Biocam Sp. z o.o.
  • 19.9. CapsoVision, Inc.
  • 19.10. Covestro AG
  • 19.11. Duomed Group
  • 19.12. Fujifilm Holding Corporation
  • 19.13. Intromedic co., Ltd
  • 19.14. JINSHAN Science & Technology (Group) Co., Ltd.
  • 19.15. Medtronic PLC
  • 19.16. MU Ltd.
  • 19.17. Olympus Corporation
  • 19.18. RF Systems Lab
  • 19.19. Shangxian Minimal Invasive Inc
  • 19.20. STERIS
  • 19.21. SynMed Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAPSULE ENDOSCOPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAPSULE ENDOSCOPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ESOPHAGEAL CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ESOPHAGEAL CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ESOPHAGEAL CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL BOWEL CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL BOWEL CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL BOWEL CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REUSABLE CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REUSABLE CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REUSABLE CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SINGLE USE CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SINGLE USE CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SINGLE USE CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CELIAC DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CELIAC DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING (OGIB), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING (OGIB), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING (OGIB), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL INTESTINE TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL INTESTINE TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL INTESTINE TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ULCER DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ULCER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ULCER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)